Hauser等认为,否定丙种球蛋白(以下简称丙球)治疗小儿复发性呼吸道感染,可能过于轻率。作者同意他们的若干论点,但仍然认为这种疗法具有潜在危险性、不方便和价格昂贵的缺点,在大多数病人中,弊远大于利。 Hauser, etc., that negative gamma globulin (hereinafter referred to as ciliary) treatment of children with recurrent respiratory tract infection may be too hasty. The authors agree with several of their arguments, but still consider the disadvantage of potentially dangerous, inconvenient and expensive such therapies, which are far more harmful to the benefit of most patients.